Joaquín Jerez
Joaquín Jerez publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments and Acute Lymphoblastic Leukemia research.
- World rank
- #6,622,225 of 7,710,434 ranked researchers
- Rank in Chile
- #17,552 of 20,642
- Works
- 27
- Citations
- 81
- Citations per work
- 3.0
What does Joaquín Jerez research?
Joaquín Jerez's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1764.5%
- Medicine1764.5%
- Everything else828.7%
- Life Sciences26.8%
- 1Hematology32% of their works
- 2Genetics10% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4Surgery7% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Molecular Biology7% of their works
Research topics
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
Which keywords describe Joaquín Jerez's research?
The keywords of their largest research topics: Prognostic Factors, Minimal Residual Disease, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Acute Lymphoblastic Leukemia, Childhood Cancer and Diagnosis Criteria.
- Myelofibrosis
- Graft-versus-Host Disease
- Bone Marrow Niche
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Diagnosis Criteria
- Acute Lymphoblastic Leukemia
- AML
- Minimal Residual Disease
- Prognostic Factors
- Hematopoietic Stem Cells
- Acute Myeloid Leukemia
- Childhood Cancer
- International Myeloma Working Group
- Imatinib
- Genomic Aberrations
- Cardiac Amyloidosis
- JAK2 Mutation
- Transthyretin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors153 topics
- Minimal Residual Disease102 topics
- Hematopoietic Stem Cells92 topics
- AML71 topic
- Acute Myeloid Leukemia71 topic
- Acute Lymphoblastic Leukemia51 topic
- Childhood Cancer51 topic
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- BCR-ABL41 topic
- Imatinib41 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Bone Marrow Niche21 topic
- Cardiac Amyloidosis21 topic
- Graft-versus-Host Disease21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
- Transthyretin21 topic
Where does Joaquín Jerez work?
Joaquín Jerez's main affiliation in the publication record is Fundación Arturo López Pérez, Chile.
How many publications and citations does Joaquín Jerez have?
OpenAlex counts 27 works and 81 citations for Joaquín Jerez, an h-index of 5, ranking #6,622,225 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Joaquín Jerez. Posts are plain text and can be reported.